• Gunjan Kumar Mandal Ph.D. Student, Department of Biochemistry, MMIMSR, Mullana, Ambala, Haryana, India
  • Dr. Suvarna Prasad Professor & Head, Department of Biochemistry, MMIMSR, Mullana, Ambala, Haryana, India
  • Dr. B.K.Agrawal Professor & Head, Department of Medicine, MMIMSR, Mullana, Ambala, Haryana, India
  • Dr. Pallav Sharma MD student, Department of Biochemistry, MMIMSR, Mullana, Ambala, Haryana, India


Diabetes mellitus, Hypertension, Lipid profile, Metabolic syndrome, Obesity, Thyroid profile


Background and Objectives: Metabolic syndrome (MetS) is a cluster of several metabolic disorders including hyperglycemia, reduced high density lipoprotein cholesterol, raised triglyceride level in serum, hypertension and abdominal obesity. Thyroid dysfunction (TD) was found to be more frequent between patients with metabolic syndrome. MetS and its related components are associated with functional and morphological alteration of the thyroid gland.  

Methods:  The present study was conducted at the MM Institute of Medical Sciences and Research. The  study  includes 300 patients with MetS as  a  case  and  300  healthy  volunteers  as  a  control. MetS was diagnosed according to international diabetes federation. Thyroid profile was assayed in various components of metabolic syndrome.

Results: It was noted that thyroid dysfunction was prevalent in 129 patients out of 300 MetS patients included in our study. Out of which, 46 patients had hypothyroidism, 18 patients had hyperthyroidism, 58 patients had subclinical hypothyroidism and 7 patients had subclinical hyperthyroidism.

Interpretation and Conclusions: Our study has decided that screening must be recommended for all MetS patients to rule out thyroid dysfunction. Both MetS and thyroid dysfunction are risk factors for cardiovascular disease (CVD).


I. Roislien J, Calster B, Hjelmesaeth J (2011). Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study. Cardiovasc Diabetol,10-17.

II. Dunbar SN, Kacharava AG: Obesity and the metabolic syndrome. Hosp physician. Available at

III. Tkac I. (2005) Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis. Diabetes Res Clin Pract.,68 (suppl): S2-9.

IV. website of the international Diabetes Federation: 2006. Accessed on 10-09-2016.

V. Hellenius M (2007) : Metabolic syndrome. Physical activity in the prevention and treatment of disease.,34,448-63. Accessed on 10-09-2016.

VI. World Health Organization, Obesity, 2013, topics/obesity/en/.

VII. Gutch M, Rungta S, Kumar S, Agarwal A, Bhattacharya A, Razi S (2017). Thyroid functions and serum lipid profile in metabolic syndrome. Biomedical journal,40,147-153.

VIII. Fathima F, Preetha (2016). Evaluation of thyroid function test in obese patients. AJPCR,9,353-355.

IX. Nazir S, Itagappa M, Hassan A (2015) : Latest Insight into the Relation of Metabolic syndrome with Thyroid Dysfunction. GJMR-F,15,5-12.

X. Iqbal A, Figenschau Y, Jorde R (2006). Blood pressure in relation to serum thyrotropin: the Tromso study. J of human hypertension ,20,932-936.

XI. Milionis A, Milionis C (2013). Correlation between body mass index and thyroid function in euthyroid individuals in Greece. Hindawi publishing corporation, ISRN Biomarkers ; 1-7

XII. Bharat, Hijam D, Gangte D, Lalnunpui, Premchand, et al (2013). Thyroid Status in Diabetes Mellitus. J Glycomics Lipidomics ;3:106. doi:10.4172/2153-0637.1000106

XIII. Bal BS, Kain PP, Singh BM, et al (2003). Prospective analysis of thyroid abnormalities in cases of type 2 diabetes mellitus. J Assoc Phys India ,51,1165.

XIV. Ahmed A, Mohamed S, Elmadi S, Abdorabo A, Ismail I, Ismail A (2017). Assessment of thyroid dysfunction in type 2 diabetes mellitus patients in Surman, Western-Libya. IJCEMS,3,1-4.

XV. Islam S, Yesmine S, Khan SA, et al (2008). A comparative study of thyroid hormone levels in diabetic and non diabetic patients. Southeast Asians J Top Med Public Health , 39,913–16.

XVI. Hung Su C, Fang C, Chen J, Po H, Chou L, Chiang C, et al (2011). Prevalence of Metabolic Syndrome and Its Relationship with Cardiovascular Disease among Hypertensive Patients 55-80 Years of Age. Acta Cardiol Sin ,27,229-37.

XVII. Kishore J, Gupta N, Kohli C, Kumar N (2016). Prevalence of Hypertension and Determination of Its Risk Factors in Rural Delhi. International Journal of Hypertension, Hindawi Publishing Corporation ;1-6

XVIII. Li N, Heizhati M, Sun C, Abulikemu S, Shao L, Yao X et al (2016). Thyroid Stimulating Hormone Is Increased in Hypertensive Patients with Obstructive Sleep Apnea. International Journal of Endocrinology, Hindawi Publishing Corporation ;1-8

XIX. Iwen K, Schroder E, Brabant G. Thyroid Hormones and the Metabolic Syndrome (2013). Eur Thyroid J ,2,83-92.

XX. Agarwal P, Singh MM, Gutch M (2015). Thyroid function and metabolic syndrome. Thyroid Res Pract ,12,85-6.

XXI. Pangaluri R, Akila S, William E (2013). Prevalence of metabolic syndrome and its components in women with subclinical hypothyroidism. ,6(4),82-84.

Additional Files



How to Cite

Gunjan Kumar Mandal, Dr. Suvarna Prasad, Dr. B.K.Agrawal, & Dr. Pallav Sharma. (2018). CORRELATION OF THE LEVELS OF THYROID HORMONES WITH VARIOUS COMPONENTS OF METABOLIC SYNDROME IN PATIENTS DIAGNOSED WITH METABOLIC SYNDROME. International Education and Research Journal (IERJ), 4(10). Retrieved from